ClinicalTrials.gov record
Recruiting Phase 1 Interventional

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

ClinicalTrials.gov ID: NCT05803382

Public ClinicalTrials.gov record NCT05803382. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase I Trial of ZEN003694 (ZEN-3694) in Combination With Capecitabine in Patients With Solid Tumors

Study identification

NCT ID
NCT05803382
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
National Cancer Institute (NCI)
NIH
Enrollment
30 participants

Conditions and interventions

Interventions

  • BET Bromodomain Inhibitor ZEN-3694 Drug
  • Biopsy Procedure Procedure
  • Biospecimen Collection Procedure
  • Capecitabine Drug
  • Computed Tomography Procedure
  • Magnetic Resonance Imaging Procedure
  • Positron Emission Tomography Procedure

Drug · Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 7, 2023
Primary completion
Jun 29, 2026
Completion
Jun 29, 2026
Last update posted
Apr 28, 2026

2023 – 2026

United States locations

U.S. sites
22
U.S. states
10
U.S. cities
17
Facility City State ZIP Site status
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine California 92612 Recruiting
UC Irvine Health/Chao Family Comprehensive Cancer Center Orange California 92868 Recruiting
UF Health Cancer Institute - Gainesville Gainesville Florida 32610 Recruiting
Memorial Hospital East Shiloh Illinois 62269 Active, not recruiting
University of Kansas Clinical Research Center Fairway Kansas 66205 Recruiting
University of Kansas Cancer Center Kansas City Kansas 66160 Recruiting
University of Kansas Hospital-Westwood Cancer Center Westwood Kansas 66205 Recruiting
Siteman Cancer Center at Saint Peters Hospital City of Saint Peters Missouri 63376 Active, not recruiting
Siteman Cancer Center at West County Hospital Creve Coeur Missouri 63141 Active, not recruiting
Washington University School of Medicine St Louis Missouri 63110 Active, not recruiting
Siteman Cancer Center-South County St Louis Missouri 63129 Active, not recruiting
Siteman Cancer Center at Christian Hospital St Louis Missouri 63136 Active, not recruiting
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York New York 10032 Active, not recruiting
Montefiore Medical Center-Einstein Campus The Bronx New York 10461 Recruiting
Montefiore Medical Center-Weiler Hospital The Bronx New York 10461 Recruiting
Montefiore Medical Center - Moses Campus The Bronx New York 10467 Recruiting
University of Cincinnati Cancer Center-UC Medical Center Cincinnati Ohio 45219 Recruiting
University of Cincinnati Cancer Center-West Chester West Chester Ohio 45069 Recruiting
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 Recruiting
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232 Recruiting
Vanderbilt Breast Center at One Hundred Oaks Nashville Tennessee 37204 Recruiting
Vanderbilt University/Ingram Cancer Center Nashville Tennessee 37232 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05803382, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 28, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05803382 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →